1. Issuer: Agimexpharm Pharmaceutical Joint Stock Company
2. Stock code: AGP
3. Par value: VND10,000/share
4. Record date: 27/11/2025
5. Ex-date: 26/11/2025
6. Reason:
* Share issue to outstanding shareholders:
- Number of shares to be issued: 3,992,290
- Exercise rate: 20:03 (Each share entitles the holder to one subscription right, and 20 rights allow the purchase of 3 new shares).
- Issue price: VND25,000/share.
- Rounding method: To ensure that the total number of shares offered does not exceed the expected offering volume, the number of additional shares that existing shareholders are entitled to subscribe for shall be rounded down to the nearest whole share. Any fractional shares (if any) shall be subject to distribution at the discretion of the Board of Directors, as authorized by the General Meeting of Shareholders, including the selection of investors, eligibility criteria, and allocation method, provided that the offering price is not lower than VND 25,000 per share
+ Example: Shareholder A, who holds 126 shares on the record date, will receive 126 subscription rights. With an allocation ratio of 20:03, Shareholder A is entitled to subscribe for 126 × 3/20 = 18.9 new shares. In accordance with the rounding-down principle, Shareholder A may subscribe for 18 new shares, while the fractional portion of 0.9 share shall be reallocated to other investors at the discretion of the Board of Directors, provided that the offering price is not lower than VND 25,000 per share.
- Treatment of fractional shares (if any) and unsubscribed or unpaid shares of existing shareholders:
The handling of fractional shares arising from rounding down (if any), as well as shares not subscribed for or not fully paid by existing shareholders, must comply with the provisions of Article 42 of Decree No. 155/2020/ND-CP dated 31 December 2020, and the regulations on capital contribution and investment in parent companies and subsidiaries as stipulated in Clause 2, Article 195 of the Law on Enterprises 2020
- The fractional shares arising from rounding down (if any), as well as the shares not subscribed for or not paid for by existing shareholders, shall be distributed at the discretion of the Board of Directors as authorized by the General Meeting of Shareholders, including the selection of investors, allocation criteria, allocation method, and offering price (which must not be lower than VND 25,000 per share)
- The fractional shares arising from rounding down, when reallocated, shall not be subject to transfer restrictions. The shares not subscribed for or not paid for by existing shareholders, when reallocated, shall be subject to a transfer restriction period of 01 year from the closing date of the offering.
In cases where the reallocation of shares falls under any of the circumstances specified in Clause 3, Article 42 of Decree No. 155/2020/ND-CP, the Board of Directors shall seek approval from the General Meeting of Shareholders prior to conducting such reallocation.
- In the event that, upon the expiry of the share distribution period prescribed by law (including any extension period, if applicable), there remain undistributed shares, such undistributed shares shall be cancelled, and the Board of Directors shall issue a resolution to close the offering. The Board of Directors shall consider and make adjustments to the capital utilization plan to ensure that the Company’s funding needs and business operations are not adversely affected.
- Blocked account:
+ Account name: Agimexpharm Pharmaceutical Joint Stock Company
+ Bank name: VietinBank – An Giang Branch
+ Account number: 117000074227
- Stock type: The subscribed shares are freely transferable.
- Time for transfer of purchase rights:
+ Start date: 04/12/2025
+ End date: 18/12/2025
- Time for registration:
+ Start date: 04/12/2025
+ End date: 25/12/2025
- Exercise Place:
+ For undeposited shares: Agimexpharm Pharmaceutical Joint Stock Company (No. 27 Nguyen Thai Hoc, Long Xuyen Ward, An Giang Province) on working days. Securities certificate and Identification Card (original copy) are required. In case of authorization, a proxy with certified seal of the local authority is further requested in addtion to the mentioned above.
+ For deposited shares: securities companies where shares of shareholders have been deposited
- Times for transfer of share purchase rights: Subscription rights may be transferred once and may not be further transferred to any third party